不同减胎方法有效性:系统综述与荟萃分析
本系统综述与荟萃分析纳入 25 项研究、共 10 683 例病例,评估终止妊娠前药物与非药物减胎方法诱导胎儿心搏停止的有效性和安全性。结果显示心内注射氯化钾的失败率最低,为 0.4%(95% CI,0.1–2.4%)。减胎方法的选择需综合考虑有效性、安全性及可行性。
要点
- 心内注射氯化钾减胎失败率最低,为 0.4%(95% CI,0.1–2.4%)。
- 羊膜腔内注射地高辛失败率最高,为 10.6%(95% CI,6.4–17.1%)。
- 研究期间共报告 4 例术后绒毛膜羊膜炎,未见其他直接相关的严重不良事件。
核心结论
- 荟萃分析的点估计值表明,最有效的减胎方法是心内注射氯化钾。
- 减胎是终止妊娠前诱导胎儿心搏停止的重要操作。
研究设计与样本
- 系统检索 MEDLINE、EMBASE、CINAHL、SCOPUS、PubMed 和 Cochrane Library 数据库,时间范围为 1991 年 1 月至 2025 年 6 月。
- 纳入孕中期或孕晚期终止妊娠前采用药物或非药物方法减胎的观察性研究和随机研究。
- 使用 ROBINS-I 工具、修订版 Cochrane RoB-2 工具和 NIH 质量评估工具进行质量评价。
- 采用随机效应模型对失败操作的比例进行荟萃分析。
主要发现
- 心内注射氯化钾的汇总失败率为 0.4%(95% CI,0.1–2.4%),异质性 I² = 0%。
- 脐带内注射氯化钾的汇总失败率为 3.2%(95% CI,1.2–8.2%),异质性 I² = 0%。
- 胎儿内注射地高辛的汇总失败率为 4.8%(95% CI,3.9–5.9%),异质性 I² = 19.0%。
- 羊膜腔内注射地高辛的汇总失败率为 10.6%(95% CI,6.4–17.1%),异质性 I² = 0%。
- 所有研究中仅报告 4 例术后绒毛膜羊膜炎,未见其他与减胎操作直接相关的显著不良事件。
关键数值与推荐
- 主要结局指标为终止妊娠前未能实现胎儿心搏停止。
- 次要结局包括减胎药物总剂量、母体并发症及减胎方法对尸检可行性和质量的影响。
- 氯化钾、利多卡因和地高辛在各注射途径下报告的剂量范围差异较大。
- 胎儿血管内注射利多卡因和氯化钾均与细胞溶解持续相关。
临床怎么用
- 心内注射氯化钾可作为失败率最低的首选减胎方法。
- 选择减胎方法时应结合安全性、可行性及具体临床场景综合考量。
- 减胎操作后需警惕绒毛膜羊膜炎的发生。
局限性
- 纳入研究对减胎药物影响尸检的评估有限。
- 各研究中减胎药物剂量报告范围差异较大,缺乏标准化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Objective To determine the efficacy and safety of different pharmacological and non-pharmacological methods of feticide to induce fetal asystole prior to termination of pregnancy (TOP). Methods MEDLINE, EMBASE, CINAHL, SCOPUS, PubMed and Cochrane Library databases were searched electronically from January 1991 to June 2025. Observational and randomized studies of feticides using pharmacological or non-pharmacological methods prior to TOP in the second or third trimester were included. The primary outcome was failure to achieve fetal asystole prior to TOP. Secondary outcomes included the total dose of feticidal agent, maternal complications and influence of feticide method on feasibility and quality of postmortem evaluation. Quality assessment of the included studies was performed using the Risk Of Bias In Non-randomized Studies of Interventions tool, Revised Cochrane Risk-of-Bias-2 tool and National Institutes of Health Quality Assessment Tools. A meta-analysis of the proportions of failed procedures was conducted using random-effects models. Results Twenty-five studies with a total of 10 683 cases were included in the systematic review. Pooled proportions of failed procedures were 0.4% (95% CI, 0.1–2.4%) (I 2 = 0%) for intracardiac potassium chloride (KCl), 3.2% (95% CI, 1.2–8.2%) (I 2 = 0%) for intrafunic KCl, 4.8% (95% CI, 3.9–5.9%) (I 2 = 19.0%) for intrafetal digoxin and 10.6% (95% CI, 6.4–17.1%) (I 2 = 0%) for intra-amniotic digoxin. A range of doses were reported for KCl, lidocaine and digoxin by all routes of injection. There were four cases of postprocedure chorioamnionitis across all studies, but no other significant adverse events related directly to feticidal procedures. There was limited assessment of the impact of feticidal agent on postmortem examinations, but fetal intravascular lidocaine and KCl were associated consistently with cell lysis. Conclusions Feticide is an important procedure to induce asystole prior to TOP. Point estimates from the meta-analysis indicate that the most effective feticidal method is intracardiac KCl. Effectiveness should be considered alongside safety and feasibility when deciding on appropriate methods for different settings. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Ultrasound in Obstetrics and Gynecology:Effectiveness of different methods of feticide: systematic review and meta‐analysis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。